基因表达是由尿皮质激素诱导的,并调解其心脏保护作用
K M Lawrence1, A Chanalaris, T Scarabelli
1Medical Molecular Biology Unit, Institute of Child Health, University College London, London, England.
Circulation
|September 18, 2002
概括
乌洛科丁是一种心脏保护剂,增强心脏细胞中Kir 6.1通道的表达. 这种特定的道活动对尿皮质激素至关重要.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乌洛科丁是一种新型心脏保护剂.
- 它保护心脏肌细胞免受缺血/再输血损伤.
- 乌洛科尔在再注射时使用时是有效的.
研究的目的:
- 为了研究尿皮质素心脏保护作用背后的分子机制.
- 为了识别由尿皮质激素诱导的特定基因表达变化.
- 确定已识别的标在尿皮质蛋白的保护作用中的作用.
主要方法:
- 在心脏肌细胞中使用基因芯片技术进行全球基因表达分析.
- 用泌尿皮质素进行治疗.
- 在孤立的心脏细胞和完整的心脏中评估心脏保护作用.
- 药理学阻断K ((ATP)) 通道 (通用和线粒体特定).
- 抑制Kir 6.1通道子单元.
主要成果:
- 尤洛科丁特别诱导Kir 6.1心脏通道亚单元的增强表达.
- 泌尿皮质素的心脏保护是由K ((ATP) 通道阻断剂阻断的.
- 心脏otrophin-1 的心脏保护作用不受这些阻断剂的影响.
- 抑制Kir 6.1增强了缺血后的心脏细胞死亡.
结论:
- 这项研究报告了第一例由心脏保护剂改变K (((ATP) 通道子单元表达的情况.
- 对于尿皮质素的心脏保护作用来说,K ((ATP) 通道的开放是必不可少的.
- 基尔6.1是尿皮质激素诱导心脏保护的关键媒介.
相关概念视频
Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
ATP Synthase: Mechanism
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
G-Protein Gated Ion Channels
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:


